TGFB1 and Hepatic fibrosis: Early studies have demonstrated the irreplaceable role of Sestrin2 in the progression of fibrotic diseases; for instance, Sestrin2 inhibits hepatic stellate cell activation and arrests TGF-β1-mediated liver fibrosis [30, 31].